Study of the Racecadotril Linearity After Single Administrations of 10, 30 and 60 mg of a New Racecadotril Formulation (Suspension) by Oral Route and Evaluation of the Comparative Bioavailability of This New Formulation Versus the Sachet Formulation (Granules) After a 60 mg Single Oral Administration in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 29 Apr 2015
At a glance
- Drugs Racecadotril (Primary)
- Indications Diarrhoea
- Focus Pharmacokinetics
- Sponsors Bioprojet
- 24 Feb 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 26 Sep 2013 New trial record
- 01 Sep 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.